Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc)
Sizes: 10μg, 50μg
Catalogue Numbers: PKSH034038-10, PKSH034038-50
Citations, Manuals and MSDS Available upon request.
Abbreviation: Butyrophilin-like9; BTNL9
Target Synonym: Butyrophilin-like protein 9; BTNL9
UNIProt ID: Q8BJE2
Target Species: Human
Expression Host: HEK293 Cells
Fusion Tag: C-Fc
Accession: Q8BJE2
Background: Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.
Sequence: Asp36-Lys257
Purity: > 95 % as determined by reducing SDS-PAGE.
Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution: Please refer to the printed manual for detailed information.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 51.8 kDa
Observed MW: 60-70 kDa
Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Research Use Only